Periodontal Health Should Be Monitored Closely in Patients With Psoriasis
Patients with psoriasis reported significantly higher values for parameters that address periodontal inflammation.
All articles by Sheila Jacobs
Dermatology, Infectious Disease Collaboration May Optimize Detection of Sexually Transmitted Infections
Over the study period, significant increases in the number of screening tests, as well as the ratio between the tests and hospital admissions, was observed.
Calcipotriol Plus Betamethasone Dipropionate Foam Offers Rapid, Effective Itch Relief in Psoriasis
Compared with foam vehicle, calcipotriol plus betamethasone dipropionate foam offers more rapid and effective itch relief, with associated significant improvements in sleep and Dermatology Life Quality Index scores.
Psoriasis, Especially Severe Disease, Associated With Increased Risk for All-Cause Mortality
Patients with psoriasis, particularly those with risk factors and severe disease, should receive appropriate screening and preventative intervention.
Examining Molecular, Histopathologic Changes With Risankizumab vs Ustekinumab in Psoriasis
Investigators observed differences and similarities in molecular and histopathologic profiles in skin lesions of patients with psoriasis treated with risankizumab vs ustekinumab.
Link Between Gut Bacteria, Atopic Dermatitis Development
The investigators sought to determine how the natural environment or diet protects potentially at-risk populations from such allergic conditions as atopic dermatitis.
Thermography Helps Diagnose Allergic vs Irritant Contact Dermatitis
Researchers sought to determine whether thermography can reliably and effectively distinguish between allergic and irritant contact dermatitis.
Noncultured Epidermal, Dermal Cell Suspension Effectively Treats Vitiligo
Researchers evaluated the efficacy of transplantation of noncultured epidermal cell suspension and noncultured dermal cell suspension vs noncultured epidermal cell suspension alone in patients with vitiligo with duration of clinical stability of 3 to 6 months.
HLA-C*06:02 Status May Be Predictive of Psoriasis Treatment Response
HLA-C*06:02 status is a predictive biomarker that influences response to adalimumab and ustekinumab in patients with psoriasis.
Tapinarof Cream Twice Daily Safe, Effective for Atopic Dermatitis
The rate of treatment success with tapinarof cream 1% applied twice daily was statistically significantly higher than the rate achieved with vehicle cream.
Next post in Dermatitis
